Recent advances in the treatment of autoimmune bullous diseases.
Takamori
K
K
Department of Dermatology, School of Medicine, Juntendo University, Urayasu Hospital, Japan.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives*; D010956:Plasmapheresis / Q000379:methods*; D011379:Prognosis; D012872:Skin Diseases, Vesiculobullous / Q000175:diagnosis / Q000628:therapy*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid